Skip to content

Interactions of sleep oscillations and synaptic scaling processes across NREM-REM sleep states in healthy aging: a combined experimental-computational approach

Interactions of sleep oscillations and synaptic scaling processes across NREM-REM sleep states in healthy aging: a combined experimental-computational approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038422
Enrollment
66
Registered
2025-11-27
Start date
2026-07-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with drug-resistant temporal lobe epilepsy

Interventions

Group 1: REM-theta-tCS: experimental nocturnal sleep with cathodal REM-specific theta-tCS in healthy older volunteers (6 Hz, between 5 and 255 µA, DC baseline at 130 µA, 1 s fade in/out, maximum curre
study part 2. Group 5: Sham Stimulation: Sham REM-specific theta-tCS during nocturnal sleep in healthy older volunteers and epilepsy patients (cross-over assignment, applicable for each participant).

Sponsors

Universitätsmedizin Greifswald
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Healthy older adults aged between 60-80 years - screening in a structured telephone interview - Epilepsy patients: >18 years of age with drug-resistant temporal lobe epilepsy - Epilepsy patients: will undergo intracranial electroencephalography as part of their clinical pre-surgical evaluation of refractory focal epilepsy with a suspected temporal / temporomesial seizure onset zone - Only participants with health insurance will be included, to ensure that incidental findings can be further investigated

Exclusion criteria

Exclusion criteria: Healthy older adults: - Neurodegenerative neurological illnesses, epilepsy or history of seizures - medication acting primarily on the central nervous system - Mini Mental Status Examination scores below 24 - Severe and untreated medical conditions - History of severe alcoholism or use of drugs - Severe psychiatric disorders such as depression (if not in remission) or psychosis - Contraindication to tDCS application - Sleep disorders (and sleep medication) - insufficient German language skills (relevant for memory testing) - the following will not lead to exclusion in the epilepsy patient group: temporal sclerosis; medication acting primarily on the central nervous system Additional exclusion criteria for epilepsy patients: - 3 ASD currently taken - severe cognitive side effects of ASD (EPITRACK with a cutoff score = 28)

Design outcomes

Primary

MeasureTime frame
Cathodal theta-tCS during REM sleep will immediately decrease E/I balance significantly more than sham tCS, as quantified by the spectral slope of the 1/f decay function in the power spectral density. The spectral slope reflects the aperiodic component of neural activity, where steeper (more negative) slopes indicate increased cortical inhibition and flatter slopes reflect higher excitation-to-inhibition ratios. This measure provides a well-established proxy of cortical E/I balance.

Secondary

MeasureTime frame
- EEG in addition to intracranial EEG data is recorded and SO. Spindle and ripple activity (spectral power and density) will be assessed. In addition the coupling between SOs, spindles and sharp-wave ripples will be evaluated as a function of stimulation condition in the following way: first the precise SO phase during which cortical spindle activity peaks will be determined, followed by the evaluation of intracranial activity in the ripple frequency range as a function of the SO-spindle coupling phase - Memory retention performance in a visual-spatial memory task and schema formation task as a function of stimulation condition, operationalized by pre- to post sleep change in % correct retrieved item locations (in visual-spatial task) and generalization accuracy and memory specificity (schema task), respectively

Countries

Germany

Contacts

Public ContactJulia Ladenbauer

Universitätsmedizin Greifswald

julia.ladenbauer@med.uni-greifswald.de+49 (0)3834 86-6815

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026